Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of dose change on the success of clinical trials

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.100988Source: DataRank Database

Effects of dose change on the success of clinical trials is a research paper published in Contemporary Clinical Trials Communications (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (11)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Aaron Ritter,Justin Miller ORCID,Charles Bernick ORCID,Guogen Shan ORCID

Live enrichment

PubMed:36117568 PMC:PMC9478360

National Institutes of Health

Grant: R01AG070849

National Institutes of Health

Grant: R03CA248006

National Institutes of Health

Grant: 7R03CA248006-02

Adaptive randomized designs for cancer clinical trials by using integer algorithms and exact Monte Carlo methods

National Institutes of Health

Grant: 1R01AG070849-01

Alzheimer's Disease: New Trial Designs for Emerging Challenges

goldLicense: CC BY NC ND

publisherhttps://api.elsevier.com/content/article/PII:S2451865422001053?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2451865422001053?httpAccept=text/plain

Unpaywallhttps://doi.org/10.1016/j.conctc.2022.100988

Europe_PMChttps://europepmc.org/articles/PMC9478360

Europe_PMChttps://europepmc.org/articles/PMC9478360?pdf=render

Fields of Study

03 medical and health sciences0302 clinical medicine0101 mathematics01 natural sciences

Keywords

Alzheimer’s diseaseStatistical PowerDose ChangeAducanumab TrialMedicine (General)R5-920Research Paper

Sustainable Development Goals

SDG 3: 3. Good health